metastatic pancreas cancer

Known as: Metastatic Tumor to the Pancreas, pancreatic cancer, metastatic, Secondary Malignant Neoplasm to the Pancreas 
A malignant neoplasm that has spread to the pancreas from another anatomic site. Representative examples include metastatic carcinomas from the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
PURPOSE GVAX pancreas, granulocyte-macrophage colony-stimulating factor-secreting allogeneic pancreatic tumor cells, induces T… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
n engl j med 365;8 nejm.org august 25, 2011 768 2. Attard G, Reid AH, A’Hern R, et al. Selective inhibition of CYP17 with… (More)
  • table 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Data are lacking on the efficacy and safety of a combination chemotherapy regimen consisting of oxaliplatin… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE The combination of gemcitabine plus bevacizumab produced a 21% response rate and a median survival of 8.8 months in a… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Treatment with gemcitabine provides modest benefits in patients with metastatic pancreatic cancer. The addition of… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Both gemcitabine (GEM) and fluoropyrimidines are valuable treatment for advanced pancreatic cancer. This open-label study… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Patients with advanced pancreatic cancer have a poor prognosis and there have been no improvements in survival since the… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Gemcitabine (Gem) is the standard treatment for advanced pancreatic cancer. Given the promising phase II results obtained… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE This phase III, randomized, open-label, multicenter study compared the overall survival associated with irinotecan plus… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The human endoglycosidase heparanase (hpa) degrades heparan-sulfate proteoglycans, which constitute prominent components of… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?